The SA Journal Diabetes & Vascular Disease Vol 12 No 1 (July 2015)

42 / 48

40 VOLUME 12 NUMBER 1 • JULY 2015
RESEARCH ARTICLE SA JOURNAL OF DIABETES & VASCULAR DISEASE
References
1. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J,
et al. The metabolic syndrome and total and cardiovascular mortality in middle-
aged men. J Am Med Assoc 2002; 288(21): 2709–2716.
2. Ford ES. Risks for all-cause mortality, cardiovascular, and diabetes associated
with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005;
28(7): 1769–1778.
3. Alberti KG MM, Zimmet PZ. Definition, diagnosis and classification of diabetes
mellitus and its complications. Part 1: diagnosis and classification of diabetes
mellitus provisional report of a WHO consultation. Diabet Med 1998; 15(7):
539–553.
4. Expert panel on detection, evaluation, and treatment of high blood cholesterol
in adults. Executive summary of the third report of the National Cholesterol
Educational Program (NCEP) expert panel on detection, evaluation, and
treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am
Med Assoc 2001; 285(19): 2486–2497.
5. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome: a new world-wide
definition. A Consensus Statement from the International Diabetes Federation.
Diabet Med 2006; 23: 469–480.
6. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;
365(9468): 1415–1428.
7. Alberti KG MM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA,
et al. Harmonizing the metabolic syndrome: A joint interim statement of the
International Diabetes Federation task force on epidemiology and prevention;
National Heart, Lung, and Blood Institute; American Heart Association; World
Heart Federation; International Atherosclerosis Society; and International
Association for the Study of Obesity. Circulation 2009; 120: 1640–1645.
8. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol
2008; 28: 629–636.
9. World Health Organisation. Non-Communicable Diseases: A Strategy for the
African Region. Harare, Zimbabwe: WHO Regional Office for Africa; 2000.
10. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases:
part I: general considerations, the epidemiologic transition, risk factors, and
impact of urbanization. Circulation. 2001; 104(22): 2746–2753.
11. Okafor IC. The metabolic syndrome in Africa: Current trends. Indian J Endocrinol
Metab 2012; 16(1): 56–66.
12. Makuyana D, Gomo Z, Munyombwe T, Matenga JA, Hakim JG. Metabolic
syndrome disorders in urban black Zimbabweans with type 2 Diabetes mellitus.
Cent Afr J Med 2004; 50(3–4): 24–29.
13. Ntyintyane LM, Panz VR, Raal FJ, Gill GV. Metabolic syndrome, undi¬agnosed
diabetes mellitus and insulin resistance are highly prevalent in urbanised South
African blacks with coronary artery disease. Cardiovasc J S Afr 2006; 17(2):
50–55.
14. Fezeu L, Balkau B, Kengne AP, Sobngwi E, Mbanya J-C. Metabolic syndrome
in a sub-Saharan African setting: central obesity may be the key determinant.
Atherosclerosis 2007;193: 70–76.
15. Ker JA, Rheeder P, Van Tonder R. Frequency of the metabolic syndrome in
screened South African corporate executives. Cardiovasc J South Afr 2007; 18:
30–33.
16. Ntandou G, Delisle H, Agueh V, Fayomi B. Abdominal obesity explains the
positive rural-urban gradient in the prevalence of the metabolic syndrome in
Benin, West Africa. Nutr Res 2009; 29: 180–189.
17. Oladapo OO, Salako L, Sodiq O, Shoyinka K, Adedapo K, Falase AO. A
prevalence of cardiometabolic risk factors among a rural Yoruba south-western
Nigerian population: a population-based survey. Cardiovasc J Afr 2010; 21(1):
26–31.
18. Motala A, Esterhuizen T, Pirie FJ, Omar MAK. The prevalence of metabolic
syndrome and determination of the optimal waist circumference cut-off points
in a rural South African Community. Diabetes Care 2011; 34: 1032–1037.
19. Akpalu J, Akpalu A, Ofei F. The metabolic syndrome among patients with
cardiovascular disease in Accra, Ghana. Ghan Med J 2011; 45(4): 161–166.
20. Kaduka LU, Kombe Y, Kenya E, Kuria E, Bore JK, Bukania ZN, Mwangi M.
Prevalence of metabolic syndrome among an urban population in Kenya.
Diabetes Care 2012; 35(4): 887–893.
21. Kengne AP, Limen SN, Sobngwi E, Djouogo CFT, Nouedoui C. Metabolic
syndrome in type 2 diabetes: comparative prevalence according to two sets of
diagnostic criteria in sub-Saharan Africans. Diabet Metab Synd 2012; 4: 22.
22. Balkau B, Charles MA. Comment on the provisional report of WHO consultation.
European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999; 16:
442–443.
23. Lin WY, Lee LT, Chen CY, Lo H, Hsia HH, Liu IL, Lin RS, Shau WY, Huang KC.
Optimal cut-off values for obesity: using simple anthropometric indices to predict
cardiovascular risk factors in Taiwan. In J Obes Relat Metab Disord 2002; 26:
1232– 1238.
24. Prinsloo J, Malan L, de Ridder JH, Potgieter JC, Steyn HS. Determining the waist
circumference cut-off which best predicts the metabolic syndrome components
in urban Africans: The SABPA Study. Exp Clin Endocrinol Diabetes 2011; 119:
599–603
25. Crowther NJ, Norris SA. The current waist circumference cut point used for
the diagnostic of metabolic syndrome in Sub-Saharan African women is not
appropriate. PLOS One 2012; 7(11): 1–8.
26. Magalhães P, Capingana DP, Silva ABT, Ferreira AVL, Sá Cunha R, Rodrigues SL,
et al. Age- and gender-specific reference values of pulse wave velocity for African
adults: Preliminary results. Age 2013; 35: 2345- 2355.
27. Capingana DP, Magalhães P, Silva ABT, Gonçalves MAA, Baldo MP, Rodrigues SL,
Simões CCF, Ferreira AVL, Mill JG. Prevalence of cardiovascular risk factors and
socioeconomic level among public-sector workers in Angola. BMC Public Health
2013; 13: 732
28. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of
low-density lipoprotein cholesterol in plasma, without use of the preparative
ultracentrifuge. Clin Chem 1972; 18: 499–502.
29. Pereira AC, Sposito AC, Mota GF, Cunha RS, Herkenhoff FL, Mill JG, et al .
Endothelial nitric oxide synthase gene variant modulates the relationship
between serum cholesterol levels and blood pressure in the general population:
new evidence for a direct effect of lipids in arterial blood pressure. Atherosclerosis
2006; 184(1): 193–200.
30. Lean MEJ, Han TS, Morrison CE. Waist circumference as a measure for indicating
need for weight management. Br Med J 1995; 311: 158–161.
31. World Health Organisation. Obesity: Preventing and managing the global
epidemic: Report of a WHO Consultation on Obesity, Geneva, 3–5 June 1997.
Geneva (CH): World Health Organisation, 1998.
hq/1998/WHO_NUT_NCD_98.1_(p1-158).pdf. Accessed 03 January 2013.
32. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age
standardization of rates. A new WHO standard. EIP/GPE/EBD. GPE discussion
paper Series. WHO 2001; 31: 1–14.
33. Youden WJ. An index for rating diagnostic tests. Cancer 1950; 3: 32–35.
34. Sumner AE, Zhou J, Doumatey A, Imoisili OE, Amoah A, Acheampong J, et al. Low
HDL-cholesterol with normal triglycerides levels is the most common lipid pattern
in West Africans and African Americans with metabolic syndrome: Implications
for cardiovascular disease prevention. CVD Prev Control 2010; 5(3): 75–80.
35. Fezeu L, Mincoulou E, Balkau B, Kengne AP, Awah P, Unwin N, et al. Association
between socioeconomic status and obesity in urban Cameroon. Int J Epidemiol
2006; 35(1): 105–111.
36. Boyko EJ, Leonetti DL, Bergstrom RW, Newell-Morris L, Fujimoto WY. Visceral
adiposity, fasting plasma insulin, and lipid and lipoprotein levels in Japanese
Americans. Int J Obes Relat Metab Disord 1996; 20: 801–808.
37. Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L. Visceral adiposity and risk
of type 2 diabetes: a prospective study among Japanese Americans. Diabetes
Care 2000; 23: 465–471.
38. Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Khan SE, et al.
Visceral adiposity and the risk of impaired glucose tolerance: a prospective study
among Japanese Americans. 2003; Diabetes Care 26: 650–655.
39. Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Khan SE, et
al. Visceral adiposity is an independent predictor of incident hypertension in
Japanese Americans. Ann Intern Med 2004; 140: 992–1000.
40. Wang Z, Ma J, Si D. Optimal cut-off values and population means of waist
circumference in different populations. Nutr Res Rev 2010; 23: 191–199.
41. Takahara M, Katakami N, Kaneto H, Noguchi M, Shimomura I. Statistical
reassessment of the association between waist circumference and clustering
metabolic abnormalities in Japanese population. J Atheroscler Thromb 2012; 19:
767–778.
42. Hayashi T, Boyko EJ, Mc-Neely MJ, Leonetti DL, Khan SE, Fujimoto WY. Minimum
waist and visceral fat values for identifying Japanese Americans at risk for the
metabolic syndrome. Diabetes Care 2007; 30: 120–127.